Tag: Xolair® (omalizumab)

Giorgi Sisters

Must See: ‘ViewFinder: Food for Thought – Food Allergies’

This documentary should be required viewing for everyone as the food allergy epidemic has affected so many in the community.
Omalizumab

Study: Treatment with Omalizumab Raises Tolerance in Patients with Severe Food...

Patients reached full tolerance for 70.4% of the tested foods which were reintroduced to the patients’ diet without the need for OIT.
Infant in Mother's Arms

Study: Anti-IgE Shots During Pregnancy May Provide a Lifetime of Protection...

"We discovered that preventing infant mice from creating antibodies would effectively diminish the risk of allergies in their adult lives."
Xolair (omalizumab)

FDA Grants Xolair Breakthrough Therapy Designation for Food Allergies

Breakthrough Therapy Designation was granted on the basis of data from seven clinical studies assessing the efficacy and safety of Xolair against a range of food allergens including peanut, milk, egg and others.
Xolair (omalizumab)

Study: Drug Increases Speed and Safety of OIT for Multiple Allergies

Combining omalizumab with OIT is safe and effective for treating multiple food allergies simultaneously.

Study: New Gene Therapy Protects Against Anaphylaxis from Peanut Allergy

The technique could also be applied to other IgE-mediated food allergies.

Connect with Us

38,209FansLike
594FollowersFollow
2,663FollowersFollow
5,443FollowersFollow
38SubscribersSubscribe